Back to Search
Start Over
Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis
- Source :
- Naunyn-Schmiedeberg's archives of pharmacology. 390(3)
- Publication Year :
- 2016
-
Abstract
- application/pdf<br />Article<br />Naunyn-Schmiedeberg's Archives of Pharmacology. 2017, 390 (3), p.261-268
- Subjects :
- 0301 basic medicine
anti-inflammatory cytokine
Time Factors
Colon
medicine.medical_treatment
Inflammation
Inflammatory bowel disease
03 medical and health sciences
Immune system
Th2 Cells
inflammatory bowel disease
medicine
Animals
Genetic Predisposition to Disease
Colitis
Cells, Cultured
Pharmacology
Mice, Knockout
Mice, Inbred BALB C
business.industry
Interleukins
Oxazolone
General Medicine
Eosinophil
Protective Factors
medicine.disease
Interleukin-10
Mice, Inbred C57BL
Disease Models, Animal
030104 developmental biology
medicine.anatomical_structure
Cytokine
Phenotype
Knockout mouse
Immunology
Interleukin 19
Lymph Nodes
medicine.symptom
Inflammation Mediators
business
IL-19
Subjects
Details
- ISSN :
- 14321912
- Volume :
- 390
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Naunyn-Schmiedeberg's archives of pharmacology
- Accession number :
- edsair.doi.dedup.....b3e9ad5bd228279584cf963c196e691c